| [1] |
Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of hepatic encephalopathy in cirrhosis[J]. J Clin Hepatol, 2018, 34(10): 2076-2089. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2018.10.007 |
| [2] |
LI XK, WANG S, LI ZG, et al. Updated key points of Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis (2018)[J]. J Clin Hepatol, 2019, 35(7): 1485-1488. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2019.07.012 |
| [3] |
ZHANG JC, WANG YG, LIN F, et al. Recent advances on the pathogenesis of hepatic encephalopathy[J/CD]. Chin J Liver Dis (Electronic Version), 2019, 11(1): 6-11. (in Chinese)
张军昌, 王永刚, 林芳, 等. 肝性脑病发病机制新进展[J/CD]. 中国肝脏病杂志(电子版), 2019, 11(1): 6-11.
|
| [4] |
LI S, WANG SJ, ZHAO YQ. Clinical features and treatment of hereditary hemorrhagic telangiectasia[J]. Medicine (Baltimore), 2018, 97(31): e11687. DOI: 10.1097/MD.0000000000011687 |
| [5] |
KRITHARIS A, AL-SAMKARI H, KUTER DJ. Hereditary hemorrhagic telangiectasia: Diagnosis and management from the hematologist's perspective[J]. Haematologica, 2018, 103(9): 1433-1443. DOI: 10.3324/haematol.2018.193003 |
| [6] |
MACRI A, WILSON AM, SHAFAAT O, et al. Osler-Weber-Rendu disease[M]. StatPearls: StatPearls Publishing, 2020.
|
| [7] |
DONALDSON JW, MCKEEVER TM, HALL IP, et al. Complications and mortality in hereditary hemorrhagic telangiectasia: A population-based study[J]. Neurology, 2015, 84(18): 1886-1893. DOI: 10.1212/WNL.0000000000001538 |
| [8] |
|
| [9] |
LU ZY, AO JY, JIANG TA, et al. A large congenital and solitary intrahepatic arterioportal fistula in an old woman[J]. World J Gastroenterol, 2009, 15(13): 1656-1659. DOI: 10.3748/wjg.15.1656 |
DownLoad:
